InMode Launches AccuTite, the Smallest RFAL Treatment for Face and Body

AccuTite enables focal RF contraction without excisional surgery.

InMode Ltd. is introducing AccuTite, the smallest Radio-Frequency Assisted Lipolysis (RFAL) device for precision fat reduction or skin contraction in the face and body.

With its sub-millimeter cannula, AccuTite enables focal RF contraction without excisional surgery. There is little or no visible scarring and minimum downtime with AccuTite. The procedure takes less than 15 minutes under local anesthesia. Results can be seen immediately with continuing improvements for several weeks following treatment. These results are maintained for up to 12 months post-RFAL procedure. AccuTite now joins InMode’s RFAL technologies.

“We are excited to offer AccuTite, the newest of our breakthrough radio frequency technologies to add to our growing product portfolio.  We continue to work together with physicians around the world to develop innovative solutions to meet the growing need for minimally invasive and non-invasive aesthetic and wellness solutions,” says Moshe Mizrahy, co-founder and Chief Executive Officer of InMode in a news release. “InMode is setting the standard for the next generation of RF developments resulting in more options with higher revenue for physicians, and less time required in the operating room,” adds President of North America, Shakil Lakhani. “We continue to provide the latest in medical advancements with our strong attention to top-of-the line quality and outcomes.”